A zebrafish melanophore model of amyloidβ toxicity

Morgan Newman*, Lachlan Wilson, Esther Camp, Giuseppe Verdile, Ralph Martins, Michael Lardelli

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

16 Citations (Scopus)

Abstract

Reliable animal models are required to facilitate the understanding of neurodegenerative pathways in Alzheimer's disease. Animal models can also be employed to search for disease-modifying drugs. The embryos and larvae of zebrafish are particularly advantageous for this purpose. For Alzheimer's disease, drugs that can ameliorate amyloidβ (Aβ) toxicity have therapeutic and/or prophylactic potential. We attempted to generate a zebrafish model of Aβ toxicity that would be viable and fertile but have a highly visible pigmentation phenotype in larvae. The larvae could then be arrayed in microtiter plates to screen compound libraries for drugs acting to reduce Aβ toxicity. We used the promoter of the zebrafish mitfa (nacre) gene to drive expression of the pathological 42 amino acid species of human Aβ, Aβ42, specifically in the highly visible melanophores (melanocytes) of transgenic zebrafish. However, the transgenic fish only showed an aberrant pigment phenotype in adults at the advanced age of 16 months. Nevertheless, our results show that alteration of zebrafish pigment pattern may be useful for analysis of toxic peptide action.

Original languageEnglish
Pages (from-to)155-159
Number of pages5
JournalZebrafish
Volume7
Issue number2
DOIs
Publication statusPublished - 1 Jun 2010
Externally publishedYes

Fingerprint Dive into the research topics of 'A zebrafish melanophore model of amyloidβ toxicity'. Together they form a unique fingerprint.

Cite this